BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/28/2020 10:56:28 AM | Browse: 692 | Download: 1074
 |
Received |
|
2020-06-01 14:37 |
|
Peer-Review Started |
|
2020-05-31 21:58 |
|
First Decision by Editorial Office Director |
|
2020-09-29 19:16 |
|
Return for Revision |
|
2020-10-04 03:23 |
|
Revised |
|
2020-10-14 02:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-26 00:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-26 04:01 |
|
Articles in Press |
|
2020-10-26 04:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-10-28 00:34 |
|
Publish the Manuscript Online |
|
2020-10-28 10:48 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maliha Naseer, Shiva Poola, Francis E Dailey, Hakan Akin and Veysel Tahan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Veysel Tahan, FACG, FACP, FEBG, MD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, 1 Hospital Drive, Columbia, MO 65212, United States. tahanv@health.missouri.edu |
| Key Words |
SARS-CoV-2; COVID-19; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Pandemic |
| Core Tip |
The current pandemic caused by coronavirus disease 2019 (COVID-19) has resulted in devastating consequences worldwide. This viral infection affecting the respiratory and gastrointestinal systems is most severe in patients with co-morbid conditions, including the immunocompromised. Patients with inflammatory bowel disease are often malnourished and on immunosuppressive medications; management of this population poses unique challenges during this time. In this review, we summarize the current evidence and understanding of the management of inflammatory bowel disease during the COVID-19 pandemic. We further outline the current guidelines for treatment of those with inflammatory bowel disease and offer education for measures to prevent infections, including COVID-19. |
| Publish Date |
2020-10-28 10:48 |
| Citation |
Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal 2020; 8(5): 383-399
|
| URL |
https://www.wjgnet.com/2308-3840/full/v8/i5/383.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v8.i5.383 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
